HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prognostic factors in recurrent breast cancer: relationships to site of recurrence, disease-free interval, female sex steroid receptors, ploidy and histological malignancy grading.

Abstract
Site of first recurrence, disease-free interval (DFI), female sex steroid receptors, ploidy measurements as well as histological grading have been analysed as potentially valuable predictive factors in 313 cases of recurrent breast cancer. Univariate and multivariate analyses show histological grading, site of recurrence and disease free interval to be useful prognostic variables when assessing prognosis once disease has recurred. High concentrations of oestrogen receptors (ER) were found in patients with bone metastases, whereas lower concentrations of ER were related to visceral recurrences. Ploidy measurements failed in this study to give any predictive information once disease recurred.
AuthorsG Blanco, K Holli, M Heikkinen, O P Kallioniemi, P Taskinen
JournalBritish journal of cancer (Br J Cancer) Vol. 62 Issue 1 Pg. 142-6 (Jul 1990) ISSN: 0007-0920 [Print] England
PMID2390476 (Publication Type: Journal Article)
Chemical References
  • Receptors, Estrogen
  • Receptors, Progesterone
Topics
  • Breast Neoplasms (epidemiology, genetics, pathology, therapy)
  • Female
  • Humans
  • Multivariate Analysis
  • Neoplasm Metastasis
  • Neoplasm Recurrence, Local
  • Ploidies
  • Receptors, Estrogen (analysis)
  • Receptors, Progesterone (analysis)
  • Risk Factors
  • Survival Analysis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: